|
A phase 3 randomized study of pembrolizumab (pembro) plus lenalidomide (len) and low-dose dexamethasone (Rd) versus Rd for newly diagnosed and treatment-naive multiple myeloma (MM): KEYNOTE-185. |
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen Oncology |
Speakers' Bureau - Amgen; Celgene; Takeda |
Research Funding - Array BioPharma; Celgene; Janssen Oncology; Millennium; Onyx; Pharmacyclics; Sanofi |
|
|
Honoraria - Abbvie; Amgen; Celgene; Janssen; Takeda |
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Pfizer; Takeda |
Research Funding - Amgen (Inst); Janssen (Inst) |
Travel, Accommodations, Expenses - Amgen; Celgene |
|
|
Consulting or Advisory Role - Amgen; Janssen; Takeda |
Speakers' Bureau - Amgen; Janssen; Takeda |
|
|
Employment - Aguettant (I) |
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen |
Consulting or Advisory Role - Amgen; Celgene; Janssen |
Travel, Accommodations, Expenses - Amgen; Janssen |
|
|
Stock and Other Ownership Interests - McKesson |
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Celgene; EMD Serono; Sandoz; Takeda |
|
|
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; Bluebird Bio; Clovis Oncology; Juno Therapeutics; Kite, a Gilead company |
Consulting or Advisory Role - ARIAD; bioTheranostics; Celgene; Epizyme |
Speakers' Bureau - AstraZeneca; Janssen |
|
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen; Merck; Takeda |
Travel, Accommodations, Expenses - Amgen |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Takeda |
Speakers' Bureau - Celgene; Janssen; Takeda |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Millennium; Novartis; Onyx |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
|
Stock and Other Ownership Interests - Merck |
Travel, Accommodations, Expenses - Merck |
Other Relationship - Merck |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
Employment - Merck Sharp & Dohme |
Stock and Other Ownership Interests - Merck Sharp & Dohme |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; MSD; Novartis; Roche; Sanofi; Takeda |